Humoral response to oligomeric human immunodeficiency virus type 1 envelope protein

Journal of Virology

Volumn 70, Issue 2, 1996, Pages 753-762

  Richardson Jr , Thomas M ^a   Stryjewski, Brenda L ^a   Broder, Christopher C ^b   Hoxie, James A ^a   Mascola, John R ^c   Earl, Patricia L ^b   Doms, Robert W ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENVELOPE PROTEIN; EPITOPE; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 41;

ANTIBODY TITER; ANTIGENICITY; ARTICLE; BINDING SITE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMORAL IMMUNITY; IMMUNE RESPONSE; PRIORITY JOURNAL; PROTEIN QUATERNARY STRUCTURE; PROTEIN STRUCTURE;

EID: 0030050009     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.2.753-762.1996     Document Type: Article

References (60)

1. Allan, J. S., J. E. Coligan, F. Barin, M. F. McLane, J. G. Sodroski, C. A. Rosen, W. A. Haseltine, W. A. Lee, and M. Essex. 1985. Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III. Science 228:1091-1094
2. Barbas, C. F., E. Björling, F. Chiodi, N. Dunlop, D. Cababa, T. M. Jones, S. L. Zebedee, M. A. A. Persson, P. L. Nara, E. Norrby, and D. R. Burton. 1992. Recombinant human Fab fragments neutralize human type 1 immunodeficiency virus in vitro Proc Natl. Acad. Sci USA 89:9339-9343
3. Berman, P. W., T. J. Gregory, L. Riddle, G. R. Nakamura, M. A. Champe, J. P. Porter, F. M. Wurm, R. D. Hershberg, E. K. Cobb, and J. W. Eichberg. 1990. Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160. Nature (London) 345: 622-625.
4. Broder, C. C., P. L. Earl, D. Long, S. T. Abedon, B. Moss, and R. W. Doms. 1994. Antigenic implications of human immunodeficiency virus type-1 envelope quaternary structure, oligomer-specific and -sensitive monoclonal antibodies. Proc. Natl. Acad. Sci. USA 91:11699-11703
5. Bugge, T. H., B. Ø. Lindhardt, L. L. Hansen, P. Kusk, E. Hulgaard, K. Holmbäck, P. J. Klasse, J. Zeuthen, and K. Ulrich. 1990 Analysis of a highly immunodominant epitope in the human immunodeficiency virus type 1 transmembrane glycoprotein. gp41. defined by a human monoclonal antibody J. Virol. 64:4123-4129.
6. Burton, D. R., J. Pyati, R. Koduri, S. J. Sharp, G. B. Thornton, P. W. H. L Parren, L. S. W. Sawyer, R. M. Hendry, N. Dunlop, P. L. Nara, M. Lamacchia, E. Garratty, E. R. Stiehm, Y. J. Bryson, Y. Cao, J. P. Moore, D. D. Ho, and C. F. Barbas. 1994. Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody. Science 266:1024-1027.
7. Clements, G. J., M. J. Price-Jones, P. E. Stephens, C. Sutton, T. F. Schultz, P. R. Clapham, J. A. McKeating, M. O. McClure, S. Thomson, M. Marsh, J. Kay, R. A. Weiss, and J. P. Moore. 1991. The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic sites, a possible function in viral fusion? AIDS Res Hum. Retroviruses 7:3-16.
8. Delwart, E. L., E. G. Shpaer, J. Louwgie, F. E. McCutchan, M. Grez, H. Rubsamenwaigmann, and J. I. Mullins. 1993. Genetic-relationships determined by a DNA heteroduplex mobility assay - analysis of HIV-1 env genes. Science 262:1257-1261.
9. Devash, Y., T. J. Matthews, J. E. Drummond, K. Javaherian, D. J. Waters, L. O. Arthur, W. A. Blattner, and J. R. Rusche. 1990 C-terminal fragments of gp120 and synthetic peptides from five HTLV-III strains, prevalence of antibodies to the HTLV-III-MN isolate in infected individuals. AIDS Res. Hum. Retroviruses 6:307-316
10. Doms, R. W., R. Lamb, J. K. Rose, and A. Helenius. 1993. Folding and assembly of viral membrane proteins. Virology 193:545-562.
11. 10a Earl, P. L., and C. C. Broder. Unpublished data
12. Earl, P. L., C. C. Broder, D. Long, S. Lee, J. Peterson, S. Chakrabarti, R. W. Doms, and B. Moss. 1994 Native oligomeric human immunodeficiency virus type 1 envelope glycoprotein elicits diverse monoclonal antibody reactivities. J Virol 68:3015-3026
13. Earl, P. L., R. W. Doms, and B. Moss. 1990. Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein. Proc Natl. Acad Sci. USA 87:648-652
14. Earl, P. L., S. Koenig, and B. Moss. 1991. Biological and immunological properties of the human immunodeficiency virus type 1 envelope glycoprotein: analysis of proteins with truncations and deletions expressed by recombinant vaccinia viruses J. Virol 65:31-41
15. Earl, P. L., and B. Moss. 1993. Mutational analysis of the assembly domain of the HIV-1 envelope glycoprotein Aids Res. Hum. Retroviruses 9:589-594.
16. Earl, P. L., B. Moss, and R. W. Doms. 1991. Folding, interaction with GRP78-BiP. assembly, and transport of the human immunodeficiency virus type 1 envelope protein. J. Virol 65:2047-2055
17. Gnann, J. W. J., J. A. Nelson, and M. B. A. Oldstone. 1987 Fine mapping of an immunodominant domain m the transmembrane glycoprotein of human immunodeficiency virus. J Virol 61:2639-2641
18. Gorny, M. K., J. P. Moore, A. J. Conley, S. Karwowska, J. Sodroski, C. Williams, S. Burda, L. J. Boots, and S. Zolla-Pazner. 1994. Human anti-V2 monoclonal antibody that neutralizes primary but not laboratory isolates of human immunodeficiency virus type 1. J. Virol. 68:8312-8320.
19. Groenink, M., J. P. Moore, S. Broersen, and H. Schuitemaker. 1995. Equal levels of gp120 retention and neutralization resistance of phenotypically distinct primary human immunodeficiency virus type 1 variants upon soluble CD4 treatment. J. Virol 69:523-527
20. Hanson, C. V. 1994. Measuring vaccine-induced HIV neutralization: report of a workshop AIDS Res Hum Retroviruses 10:645-648.
21. Ho, D. D., M. S. C. Fung, H. Yoshiyama, Y. Cao, and J. E. Robinson. 1992. Discontinuous epitopes on gp120 important in HIV-1 neutralization. AIDS Res. Hum. Retroviruses 8:1337-1339.
22. Ho, D. D., J. A. McKeating, X. L. Li, T. Moudgil, E. S. Daar, N.-C. Sun, and J. E. Robinson. 1991. Conformational epitopc on gp120 important in CD4 binding and human immunodeficiency virus type 1 neutralization identified by a human monoclonal antibody. J. Virol. 65:489-493.
23. Hurtley, S. M., and A. Helenius. 1989 Protein oligomerization in the endoplasmic reticulum. Annu. Rev. Cell Biol. 5:277-307
24. Ichimura, H., S. C. Kliks, S. Visrutaratna, C.-Y. Ou, M. L. Kalish, and J. A. Levy. 1994. Biological, serological, and genetic characterization of HIV-1 subtype E isolates from northern Thailand. AIDS Res. Hum. Retroviruses 10:263-269.
25. Kurstak, E., P. Tijssen, C. Kurstak, and R. Morisset. 1986. Enzyme immunoassays and related procedures in diagnostic medical virology. Bull. WHO 64:465-479.
26. Lasky, L. A., J. E. Groopman, C. W. Fennie, P. M. Benz, D. J. Capon, D. J. Dowbenko, G. R. Nakamura, W. M. Nunes, M. E. Renz, and P. W. Berman. 1986. Neutralization of the AIDS retrovirus by antibodies to a recombinant envelope glycoprotein. Science 233:209-212.
27. Mascola, J. R., J. Louwagie, F. E. McCutchan, C. L. Fischer, P. A. Hegerich, K. F. Wagner, A K. Fowler, J. G. McNeil, and D. S. Burke. 1994. Two antigenically distinct subtypes of human immunodeficiency virus type 1 viral genotype predicts neutralization serotype. J. Infect. Dis. 169:48-54.
28. Mascola, J. R., S. W. Snyder, O. S. Weislow, S. M. Belay, R. B. Belshe, M. L. Clements, R. Dolin, B. S. Graham, G. J. Gorse, M. C. Keefer, M. J. McElrath, D. H. Schwartz, M. C. Walker, P. E. Fast, J. G. McNeil, F. E. McCutchan, and D. S. Burke. Immunization with envelope subunit vaccine products elicit neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1. J. Infect, Dis., in press.
29. McKeating, J. A., J. Cordell, C. J. Dean, and P. Balfe. 1992. Synergistic interaction between ligands binding to the CD4 binding site and V3 domain of human immunodeficiency virus type 1 gp120. Virology 191:732-742.
30. Moore, J., G. K. Lewis, and J. Robinson. 1993. Which gp160 vaccine? Nature (London) 361:503.
31. Moore, J. P., Y. Cao, L. Qing, Q. J. Sattentau, J. Pyati, R. Koduri, J. Robinson, C. F. Barbas, III. D. R. Burton, and D. D. Ho. 1995. Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies, and their neutralization is, not predicted by studies with monomeric gp120. J. Virol. 69:101-109.
32. Moore, J. P., and D. D. Ho. 1993. Antibodies to discontinuous or conformationaily sensitive epitopes on the gp120 glycoprotein of human immunodeficiency virus type 1 are highly prevalent in sera of infected humans. J. Virol. 67:863-875.
33. Moore, J. P., F. E. McCutchan, S.-W. Poon, J. Mascola, J. Liu, Y. Cao, and D. D. Ho. 1994. Exploration of antigenic variation in gp120 clades A through F of human immunodeficiency virus type 1 by using monoclonal antibodies. J Virol 68:8350-8364.
34. Moore, J. P., J. A McKeating, Y. Huang, A. Ashkenazi, and D. D. Ho. 1992. Virions of primary human immunodeficiency virus type 1 isolates resistant to soluble CD4 (sCD4) neutralization differ in sCD4 binding and glycoprotein gp120 retention from sCD4-scnsitive isolates. J. Virol 66:235-243.
35. Moore, J. P., Q. J. Sattentau, R. Wyatt, and J. Sodroski. 1994 Probing the structure of the human immunodeficiency virus surface glycoprotein gp120 with a panel of monoclonal antibodies. J. Virol 68:469-484
36. Moore, J. P., Q. J. Sattentau, H. Yoshiyama, M. Thali, M. Charles, N. Sullivan, S. Poon, M. S. Fung, F. Traincard, M. Pinkus, G. Robey, J. E. Robinson, D. D. Ho, and J. Sodroski. 1993 Probing the structure of the V2 domain of human immunodeficiency virus type 1 surface glycoprotein gp120 with a panel of eight monoclonal antibodies: human immune response to the VI and V2 domains. S Virol 67:6136-6151
37. Moore, J. P., M. Thali, B. A Jameson, F. Vignaux, G. K. Lewis, S. Poon, M. Charles, M. S. Fung, B. Sun, P. J. Durda, L. Akerblom, B. Wahren, D. D. Ho, Q. J. Sattenlau, and J. Sodroski. 1993. Immunochemical analysis of the gp120 surface glycoprotein of human immunodeficiency virus type 1: probing the structure of the C4 and V4 domains and the interaction of the C4 domain with the V3 loop. J. Virol. 67:4785-4796
38. Moore, J. P., H. Yoshiyama, D. D. Ho, J. E. Robinson, and J. Sodroski. 1993. Antigenic variation in gp120s from molecular clones of HIV-1 LAI. AIDS Res. Hum. Retroviruses 9:1185-1193.
39. Nara, P. L., R. R. Garrity, and J. Goudsmit. 1991 Neutralization of HIV-1. a paradox of humoral proportions FASEB J 5:2437-2455.
40. Orloff, S. L., M. S. Kennedy, A. S. Belperron, P. J. Maddon, and J. S. McDougal. 1993 Two mechanisms of soluble CD4 (sCD4) mediated inhibition of human immunodeficiency virus type 1 isolates with reduced sensitivity to sCD4. J. Virol. 67:1461-1471.
41. Pinter, A., W. J. Honnen, S. A. Tilley, C. Bona, H. Zaghouani, M. K. Gorny, and S. Zolla-Pazner. 1989. Oligomeric structure of gp41, the transmembrane protein of human immunodeficiency virus type 1 J. Virol. 63:2674-2679.
42. Posner, M. R., L. A. Cavacini, C. L. Emes, J. Power, and R. Byrn. 1993. Neutralization of HIV-1 by F105, a human monoclonal antibody to the CD4 binding site of gp120 J Acquired Immune Defic. Syndr. 6:7-14.
43. Poumbourios, P., W. E. Ahmar, D. A. McPhee, and B. E. Kemp. 1995. Determinants of human immunodeficiency virus type 1 envelope protein oligomeric structure J. Virol. 69:1209-1218.
44. Poumbourios, P., D. A. McPhee, and B. E. Kemp. 1992. Antibody epitopes sensitive to the state of human immunodeficiency virus type 1 gp41 oligomerization map to a putative α-helical region. AIDS Res. Hum Retroviruses 8:2055-2062.
45. Putney, S. D., T. J. Matthews, W. G. Robey, D. L. Lynn, M. Robert-Guroff, W. T. Mueller, A. J. Langlois, J. Ghrayeb, S. R. Petteway, K. J. Weinhold, P. J. Fischinger, F. Wong-Staal, R. C. Gallo, and D. P. Bolognesi. 1986. HTLV-III/LAV-rieutralizing antibodies to an E. coli produced fragment of the virus envelope Science 234:1392-1395.
46. Roben, P., J. P. Moore, M. Thali, J. Sodroski, C. F. Barbas, and D. R. Burton. 1994 Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1. J. Virol. 68:4821-4828
47. Robey, W. G., L. O. Arthur, T. J. Matthews, A. Langlois, T. D. Copeland, N. W. Lerche, S. Oroszlan, D. P. Bolognesi, R. V. Gilden, and P. J. Fischinger. 1986. Prospect for prevention of human immunodeficiency virus infection: purified 120-kDa envelope glycoprotein induces neutralizing antibody Proc. Natl Acad Sci. USA 83:7023-7027.
48. Sattentau, Q. J., and J. P. Moore. 1991 Conformational changes in the human immunodeficiency virus envelope glycoproteins by soluble CD4 binding. J. Exp. Med. 174:407-415.
49. Sattentau, Q. J., and J. P. Moore. 1995 HIV-I neutralization is determined by epitopc exposure on the gp120 oligomer. J. Exp. Med. 182:185-196.
50. Sattentau, Q. J., S. Zolla-Pazner, and P. Poignard. 1995. Epitope exposure on functional, oligomeric HIV-1 gp41 molecules. Virology 206:713-717.
51. Schawaller, M., C. E. Smith, J. J. Skehel, and D. C. Wiley. 1989. Studies with cross-linking reagents on the oligomeric structure of the env-olycoprotein of HIV. Virology 172:367-369.
52. Starcich, B. R., B. H. Hahn, G. M. Shaw, P. D. McNeely, S. Modrow, H. Wolf, E. S. Parks, W. P. Parks, S. F. Josephs, R. C. Gallo, and F. Wong-Slahl. 1986. Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV. the retrovirus of AIDS. Cell 45: 637-648
53. Steimer, K. S., C. J. Scandella, P. V. Skiles, and N. L. Haigwood. 1991. Neutralization of divergent HIV-1 isolates by conformation-dependent human antibodies to gp120. Science 254:105-108
54. Thali, M., C. Furman, B. Wahren, M. Posner, D. D. Ho, J. Robinson, and J. Sodroski. 1992. Oxtperativity of neutralizing antibodies directed against the V3 and CD4 binding regions of the human immunodeficiency virus gp120 envelope glycoprotein. J. Acquired Immune Defic Syndr 5:591-599
55. Thali, M., U. Olshevsky, C. Furman, D. Gabuzda, M. Posner, and J. Sodroski. 1991 Characterization of a discontinuous human immunodeficiency virus type 1 gp120 epitope recognized by a broadly neutralizing human monoclonal antibody. J. Virol 65:6188-6193
56. Thomas, D. J., J. S. Wall, J. F. Hainfeld, M. Kaczorek, F. P. Booy, B. L. Trus, F. A. Eiserling, and A. C. Steven. 1991 gp160. the envelope glycoprotein of human immunodeficiency virus type 1, is a dimer of 125-kilodalton subunits stabilized though interactions between their gp41 domains. J Virol. 65:3797-3803
57. Tilley, S. A., W. F. Honnen, M. Radio, M. Hilgartner, and A. Pinter. 1991 A human monoclonal antibody against the CD4 binding site of HIV-1 gp 120 exhibits potent, broadly neutralizing activity Res Virol 142:247-259.
58. Tilley, S. A., W. J. Honnen, M. E. Racho, T.-C. Chou, and A. Pinter. 1992. Synergistic neutralization of HIV-1 by human monoclonal antibodies against the V3 loop and the CD4-binding site of gp120. AIDS Res. Hum. Retroviruses 8:461-4-67.
59. Weiss, C. D., J. A. Levy, and J. M. White. 1990. Oligomeric organization of gp120 on infectious human immunodeficiency virus type 1 particles. J. Virol. 64:5674-5677.
60. Xu, J.-Y., M. K. Gorny, T. Palker, S. Karwowska, and S. Zolla-Pazner. 1991. Epitope mapping of two immunodonimant domains of gp41, the transmembrane protein of human immunodeficiency virus type 1. using ten human monoclonal antibodies. J Virol. 65:4832-4838